University of Manitoba: Communicable Diseases trials
The registry lists 11 Communicable Diseases studies with University of Manitoba as lead sponsor. 1 are open to participants now and 0 have results posted.
Phase 1 1Phase 2 1Phase 3 1Phase 4 2No phase 7(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Powdered Intrawound Vancomycin in Open Fractures TrialNot yet recruitingNCT06504992Phase 4
- The Prospective Evaluation of Peri-Operative Glucocorticoid Use in the Management of Cervicofacial Infections of Odontogenic OriginCompletedNCT05951504Phase 2/3
- The CHILD Cohort COVID-19 Add-On StudyCompletedNCT05234359
- Is Cefazolin, Ceftazidime and Ciprofloxacin Dosing Optimal in Hemodialysis Patients?CompletedNCT04319328
- Matching Donor Human Milk On Maternal Secretor Status (MMOMSS) StudyTerminatedNCT04130165Not applicable
- Human-derived Human Milk Fortifiers (H2MF), Gut Microbiota and Oxidative Stress in Premature InfantsCompletedNCT03214822Not applicable
- The AVATAR Trial: Applying VAcuum To Accomplish Reduced Wound InfectionsTerminatedNCT01623427Not applicable
- DNA-based Influenza Vaccine in the ElderlyCompletedNCT01587131Phase 1
- Severe Pandemic H1N1 Infection in ICU: Comparative Resource UtilizationCompletedNCT01485237
- Study of the Relative Oral Bioavailability of the Antiflu Medicine Oseltamivir in the Intensive Care UnitWithdrawnNCT00844155Not applicable
- Urinary Tract Infection Study With the Antibiotic Levofloxacin Given at a Higher Dose Over a Shorter Period of TimeTerminatedNCT00245791Phase 4